Search

Your search keyword '"Complement C3b Inactivator Proteins genetics"' showing total 200 results

Search Constraints

Start Over You searched for: Descriptor "Complement C3b Inactivator Proteins genetics" Remove constraint Descriptor: "Complement C3b Inactivator Proteins genetics"
200 results on '"Complement C3b Inactivator Proteins genetics"'

Search Results

1. Anti-factor H autoantibodies in patients with lupus nephritis.

2. A case of non-lupus full-house nephropathy diagnosed by kidney biopsy but observed IgA nephropathy on second biopsy.

3. Factor H-related protein 1 in systemic lupus erythematosus.

4. Production, purification, and quality assessment of borrelial proteins CspZ from Borrelia burgdorferi and FhbA from Borrelia hermsii.

5. CFH Haploinsufficiency and Complement Alterations in Early-Onset Macular Degeneration.

6. Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication.

8. CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome.

9. Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion.

10. Copy number variation analysis using next-generation sequencing identifies the CFHR 3/ CFHR 1 deletion in atypical hemolytic uremic syndrome: a case report.

11. An Infant Case of Streptococcus Pneumoniae-Associated Thrombotic Microangiopathy with Heterozygous CFI Mutation and CFHR3-CFHR1 Deletion.

12. De novo systemic atypical hemolytic uremic syndrome in an ABO-incompatible living kidney transplant recipient with a novel pathogenic CFHR1 gene mutation successfully treated with eculizumab: a case report.

13. Anti-factor H antibody and its role in atypical hemolytic uremic syndrome.

14. Unraveling Structural Rearrangements of the CFH Gene Cluster in Atypical Hemolytic Uremic Syndrome Patients Using Molecular Combing and Long-Fragment Targeted Sequencing.

15. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy.

16. Complement Factor H related protein 1 and immune inflammatory disorders.

17. High prevalence of CFHR deletions in Indian women with pregnancy-associated hemolytic uremic syndrome.

18. Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion.

19. Benefits of genetic and immunohistochemical markers in understanding abnormalities in aging retina.

20. Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease.

21. Thrombotic microangiopathy associated with arboviral infection: Report of 3 cases.

22. Beyond factor H: The impact of genetic-risk variants for age-related macular degeneration on circulating factor-H-like 1 and factor-H-related protein concentrations.

23. Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration.

24. Complement Genetic Variants and FH Desialylation in S. pneumoniae -Haemolytic Uraemic Syndrome.

25. Pediatric Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab.

26. Case Report: Severe Complement-Mediated Thrombotic Microangiopathy in IgG4-Related Disease Secondary to Anti-Factor H IgG4 Autoantibodies.

27. Clinical and Genetic Characteristics of Atypical Hemolytic Uremic Syndrome in Children: A Chinese Cohort Study.

28. Factor H Autoantibodies and Complement-Mediated Diseases.

29. Tuning the Functionality by Splicing: Factor H and Its Alternative Splice Variant FHL-1 Share a Gene but Not All Functions.

30. Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.

31. A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes.

32. Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

33. CFHR1 is a potentially downregulated gene in lung adenocarcinoma.

34. Altered Peripheral Blood Leucocyte Phenotype and Responses in Healthy Individuals with Homozygous Deletion of FHR1 and FHR3 Genes.

35. Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical Association.

36. Carfilzomib-induced aHUS responds to early eculizumab and may be associated with heterozygous CFHR3-CFHR1 deletion.

37. Shiga Toxin as a Potential Trigger of CFHR1 Deletion-Associated Thrombotic Microangiopathy.

38. A Heterozygous CFHR3-CFHR1 Gene Deletion in a Pediatric Patient With Transplant-associated Thrombotic Microangiopathy Who was Treated With Eculizumab.

39. Evaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration.

40. Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion-rapid remission following complement blockade.

41. The complement factor H (CFH) and its related protein 2 (CFHR2) mediating immune response in large yellow croaker Larimichthys crocea.

42. The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential.

43. Germline mutations in the alternative pathway of complement predispose to HELLP syndrome.

44. Atypical presentation of atypical haemolytic uraemic syndrome.

45. Deletion Variants of CFHR1 and CFHR3 Associate with Mesangial Immune Deposits but Not with Progression of IgA Nephropathy.

46. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.

47. Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome.

48. Modulation of the Alternative Pathway of Complement by Murine Factor H-Related Proteins.

49. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.

50. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.

Catalog

Books, media, physical & digital resources